2000
HTLV-II and Bacterial Infections Among Injection Drug Users
Safaeian M, Wilson L, Taylor E, Thomas D, Vlahov D. HTLV-II and Bacterial Infections Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 24: 483-487. DOI: 10.1097/00126334-200008150-00012.Peer-Reviewed Original ResearchHTLV-II infectionInjection drug usersHTLV-IIBacterial pneumoniaInfective endocarditisOdds ratioBacterial infectionsDrug usersChart reviewConditional logistic regression methodsSelf-reported skinStandardized chart reviewOngoing cohort studyCase-control studyEnzyme-linked immunosorbentCohort studyHIV statusSkin abscessesRisk factorsControl studyEndocarditisInfectionImmunofluorescent assayPneumoniaLogistic regression methodHTLV-II and Bacterial Infections Among Injection Drug Users
Safaeian M, Wilson L, Taylor E, Thomas D, Vlahov D. HTLV-II and Bacterial Infections Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 24: 483-487. DOI: 10.1097/00042560-200008150-00014.Peer-Reviewed Original ResearchConceptsHTLV-II infectionInjection drug usersHTLV-IIBacterial pneumoniaInfective endocarditisOdds ratioBacterial infectionsDrug usersChart reviewConditional logistic regression methodsSelf-reported skinStandardized chart reviewOngoing cohort studyCase-control studyEnzyme-linked immunosorbentCohort studyHIV statusResults PrevalenceSkin abscessesRisk factorsControl studyEndocarditisInfectionImmunofluorescent assayPneumonia
1999
Self-Reported Bacterial Infections Among Women with or at Risk for Human Immunodeficiency Virus Infection
Flanigan T, Hogan J, Smith D, Schoenbaum E, Vlahov D, Schuman P, Mayer K. Self-Reported Bacterial Infections Among Women with or at Risk for Human Immunodeficiency Virus Infection. Clinical Infectious Diseases 1999, 29: 608-612. PMID: 10530455, DOI: 10.1086/598641.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionCD4 cell countImmunodeficiency virus infectionBacterial infectionsRecent pneumoniaVirus infectionCell countHIV-negative womenHIV-seropositive womenUrinary tract infectionInjection drug useLogistic regression analysisSelf-reported pneumoniaCross-sectional analysisSeronegative womenTract infectionsHIV infectionDrug useLifetime historyInfectionPneumoniaMajor causeWomenRegression analysisCell categoriesCell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men
Lyles C, Graham N, Astemborski J, Vlahov D, Margolick J, Saah A, Farzadegan H. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. European Journal Of Epidemiology 1999, 15: 99-108. PMID: 10204638, DOI: 10.1023/a:1007556327269.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAIDS-Related Opportunistic InfectionsBacterial InfectionsCause of DeathCD4 Lymphocyte CountCohort StudiesConfidence IntervalsDisease ProgressionFemaleFollow-Up StudiesHIV InfectionsHIV-1Homosexuality, MaleHumansImmunocompromised HostLeukocytes, MononuclearMalePredictive Value of TestsProportional Hazards ModelsRisk FactorsSubstance Abuse, IntravenousSurvival AnalysisSurvival RateViral LoadViremiaConceptsHIV-1 viral loadViral loadHomosexual menRisk groupsHIV-1Relative hazardDrug usersPeripheral blood mononuclear cellsMicroculture techniqueBlood mononuclear cellsInjection drug usersHIV-1 progressionInitial CD4Clinical progressionMononuclear cellsNegative culturesPredictive valueSurvival analysisBacterial infectionsTotal participantsAIDSProgressionInfectious unitsCells/Death
1992
Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users.
Chaisson R, Taylor E, Margolick J, Muñoz A, Solomon L, Cohn S, Nelson K, Vlahov D. Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 456. PMID: 1348535, DOI: 10.1097/00126334-199205000-00004.Peer-Reviewed Original ResearchConceptsCD4 cell countSerum immune markersDrug use patternsCell countCD4 countHIV statusImmune markersImmune activationDrug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive individualsImmunodeficiency virus infectionSerum IgA levelsIntravenous drug usersAssociation of raceIgA levelsNeopterin levelsSerum markersVirus infectionLarge cohortBacterial infectionsHIVHepatitisInfectionMarkersBacterial infections and skin cleaning prior to injection among intravenous drug users.
Vlahov D, Sullivan M, Astemborski J, Nelson K. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Reports 1992, 107: 595-8. PMID: 1410243, PMCID: PMC1403704.Peer-Reviewed Original Research
1986
Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management
Walsh T, Bustamente C, Vlahov D, Standiford H. Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management. Infection Control And Hospital Epidemiology 1986, 7: 16-22. PMID: 3633240, DOI: 10.1017/s0195941700063736.Peer-Reviewed Original ResearchConceptsPeripheral thrombophlebitisBroad-spectrum antibiotic therapyCatheter site careSegmental venous resectionIntravenous amphotericin BDuration of hospitalizationCandida speciesAcute care hospitalsNosocomial fungal infectionsSuppurative thrombophlebitisVenous resectionCatheter siteAntibiotic therapyPalpable cordRisk factorsSite careCandidal colonizationRational therapyPatientsAmphotericin BBacterial infectionsThrombophlebitisFungal infectionsTherapyInfection